Evidence map›Paper›PMID 36009827›Full record

ArticleBiology2022

New PCL/PEC Blends: In Vitro Cell Response of Preosteoblasts and Human Mesenchymal Stem Cells.

Jesus L Pablos, Mónica Cicuéndez, María Hernández-Rivas, Fernando Catalina, María Vallet-Regí, Teresa Corrales

Open access · goldAbstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jesus L PablosDepartamento de Química Macromolecular Aplicada, Grupo de Fotoquímica, Instituto de Ciencia y Tecnología de Polímeros, C.S.I.C., Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0001-8504-8836
Mónica CicuéndezDepartamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain.
María Hernández-RivasDepartamento de Química Macromolecular Aplicada, Grupo de Fotoquímica, Instituto de Ciencia y Tecnología de Polímeros, C.S.I.C., Juan de la Cierva 3, 28006 Madrid, Spain.
Fernando CatalinaDepartamento de Química Macromolecular Aplicada, Grupo de Fotoquímica, Instituto de Ciencia y Tecnología de Polímeros, C.S.I.C., Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-4620-8582
María Vallet-RegíDepartamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain.ORCID 0000-0002-6104-4889
Teresa CorralesDepartamento de Química Macromolecular Aplicada, Grupo de Fotoquímica, Instituto de Ciencia y Tecnología de Polímeros, C.S.I.C., Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-0171-2283
Instituto de Ciencia y Tecnología de Polímeros · ESUniversidad Complutense de Madrid · ES

Funding

Ministry of Economy, Industry and Competitiveness MAT2017- 88923Ministry of Economy, Industry and Competitiveness PID2021-124926NB-I00
6 · The paper itself

Abstract

In this study, new blends of PCL/PEC have been prepared in an easy manner by casting with the objective of obtaining new biomaterials to apply to tissue engineering and bone regeneration. The PCL/PEC blends obtained, together with neat polymer blends, were characterized by infrared spectroscopy (FTIR), atomic force microscopy (AFM), scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). This full characterization is the key to disentangle the miscibility, which means good compatibility, of the polymer blends used in this work. The addition of increasing amounts of PEC, has shown in the new biomaterials obtained, a remarkable improvement in relation with the mechanical properties (manageable materials) and above all, in terms of an increase in their hydrophilic character with respect to the PCL neat polymer. The improvement of all these properties is reflected in their biological properties. With these thoughts in mind, the blends obtained were tested through the assessment of several biological parameters such as cell viability, proliferation, and differentiation of both the MC3T3-E1 osteoblastic cell line and hMSCs to evaluate their cell response to different polymer membranes aimed at bone tissue regeneration. "In vitro" biocompatibility methods have been chosen rather than in vivo studies due to their lower cost, faster procedure time, and minimum ethical concerns, and because it was the first time that the biological effects of these blends were studied. The results show that the PCL/PEC blends obtained, with tunable properties in terms of hydrophilic character and hydrolytic degradation, may be regarded as good candidates to perform "in vivo" tests and check their real-life applicability for bone regeneration. The polymer acronym (the weight percentage in the sub index) is PCLx/PECy as noted in table one with the summary of compositions.

Indexed as

biocompatible polymersbone regenerationcell proliferationdifferentiationPCL/PEC blendstissue engineering

Identifiers

PMID36009827
PMCPMC9404747
OpenAlexW4292506170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.